Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 7Terminated 3Unknown 2Recruiting 2Suspended 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Weight Loss 1Polycystic Ovary Syndrome 1Neoplasms 1Muscular Atrophy 1Muscle Weakness 1Motor Activity 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Carnitine × Clear all
NCT03151291 2018-10-16

Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients

University of Erlangen-Nürnberg Medical School

Phase NA Unknown
200 enrolled

Motor Activity, Muscular Atrophy, Neoplasms, Weight Loss, Muscle Weakness

NCT01665547 2013-09-10

Adding L-carnitine in Clomiphene Resistant Polycystic Ovary Improves the Quality of Ovulation and the Pregnancy Outcome

Woman's Health University Hospital, Egypt

Phase 4 Unknown
157 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡